ArticleJournal of gastrointestinal oncology2026
A retrospective study on the outcomes of yttrium-90 radiation segmentectomy with resin microspheres compared to microwave ablation for early primary hepatocellular carcinoma.
Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Yttrium-90 (Y-90) radiation segmentectomy (RS) has become an established method for interventional radiologists to treat hepatocellular carcinoma (HCC). Literature suggests similar tumor response and overall survival (OS) rates between Y-90 RS using glass microspheres and percutaneous microwave ablation (MWA) in early-stage HCC, with a potential improvement in progression-free survival (PFS) for Y-90 RS. However, the literature does not address the use of Y-90 RS with resin microspheres when compared to MWA. The aim of this study is to evaluate the efficacy of Y-90 RS with resin microspheres Methods: From 2016 to 2024, 60 patients were included in this retrospective study (20 RS and 40 MWA). Wilcoxon rank sum and Pearson's χ Results: In the overall study population, both groups had similar baseline characteristics except for greater tumor diameter in the RS group (P<0.001). The percent of complete tumor response was similar, with 82.50% in MWA Conclusions: The study suggests Y-90 RS with resin achieves similar tumor response, PFS, and OS compared to MWA in the management of AJCC stage 1 solitary tumor HCC lesions ≤4 cm. These findings were demonstrated despite the RS cohort having a larger tumor diameter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.